Puma Biotechnology Inc short interest in 2020
In 2020, Puma Biotechnology Inc's disclosed short interest ran from 20.08% of shares outstanding on 15 Jan 2020 to 16.79% on 31 Dec 2020, a change of -3.29 percentage points. The year's high was 21.94% on 31 Mar 2020 and its low 16.79% on 31 Dec 2020, averaging 19.19% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.96 days on 30 Oct 2020. Full history: Puma Biotechnology Inc.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 20.08% (15 Jan 2020)
- End of year
- 16.79% (31 Dec 2020)
- Change
- -3.29 pp
- High
- 21.94% (31 Mar 2020)
- Low
- 16.79% (31 Dec 2020)
- Average
- 19.19%
- Highest days to cover
- 18.96 (30 Oct 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 20.08% | 5.57 | |
| 31 Jan 2020 | 20.41% | 5.05 | |
| 14 Feb 2020 | 18.84% | 1.79 | |
| 28 Feb 2020 | 18.16% | 3.41 | results (8-K), 10-K filed |
| 13 Mar 2020 | 18.75% | 6.05 | |
| 31 Mar 2020 | 21.94% | 6.31 | |
| 15 Apr 2020 | 21.66% | 8.59 | |
| 30 Apr 2020 | 20.21% | 10.19 | |
| 15 May 2020 | 20.02% | 5.69 | 10-Q filed, results (8-K) |
| 29 May 2020 | 18.91% | 9.54 | |
| 15 Jun 2020 | 18.75% | 8.23 | |
| 30 Jun 2020 | 17.32% | 5.70 | |
| 15 Jul 2020 | 17.54% | 7.89 | |
| 31 Jul 2020 | 17.81% | 12.27 | |
| 14 Aug 2020 | 18.50% | 6.07 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 18.77% | 14.27 | |
| 15 Sep 2020 | 18.60% | 12.60 | |
| 30 Sep 2020 | 18.31% | 12.51 | |
| 15 Oct 2020 | 19.73% | 15.43 | |
| 30 Oct 2020 | 20.11% | 18.96 | |
| 13 Nov 2020 | 20.32% | 14.68 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 19.48% | 16.25 | |
| 15 Dec 2020 | 19.63% | 10.48 | |
| 31 Dec 2020 | 16.79% | 13.35 |
See also: Puma Biotechnology Inc's full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.